Global Automated External Defibrillator Market Size, Share & Trends Analysis Report By Product (Fully-automated, and Semi-automated), By End-use (Hospital, Pre Hospital, Public Access, Homecare, and Others), By Regional Outlook and Forecast, 2023 - 2030
자동 체외 제세동기 시장 규모는 예측 기간 동안 9.6%의 연평균 복합 성장률(CAGR)로 성장하여 2030년까지 31억 달러에 달할 것으로 예상됩니다. 2022년에는 시장 규모가 8,765.9백만 대에 도달했고, 9.0%(2019-2022년)의 성장률을 나타냈습니다.
또한 노인은 관상동맥질환, 심부전, 부정맥 등 심혈관 질환에 걸리기 쉽다. 세계보건기구에 따르면 2030년까지 6명 중 1명이 60세 이상이 될 것이라고 합니다. 전 세계 60세 이상 인구는 2020년 10억 명에서 2050년 14억 명으로 증가할 것이며, 2050년에는 전 세계 60세 이상 인구가 21억 명, 2050년에는 80세 이상 인구가 4억 2,600만 명에 달할 것으로 예상됩니다.
그러나 예산이 한정된 중소기업의 경우, AED 유지보수 및 교육 관련 비용은 엄청난 금액이 될 수 있습니다. 조직은 외부 교육 제공업체에 의존할 수 있으며, 관련 비용은 다를 수 있습니다. 외부 기관에 의존하는 경우 예측할 수 없는 비용이 발생할 수 있으며, 기업이나 기관이 효과적으로 예산을 책정하는 데 어려움을 겪을 수 있습니다. 따라서 유지보수 및 교육 비용으로 인해 시장 성장이 둔화될 수 있습니다.
또한, 전 세계 제조 및 공급망의 혼란은 AED를 포함한 의료기기의 생산 및 유통에 영향을 미쳤습니다. 이동 제한, 봉쇄, 인력 부족으로 인해 AED 공급이 지연되고 혼란이 발생했습니다. 팬데믹은 의료 자원에 부담을 주었고, 코로나19 환자 관리와 치료에 중점을 두게 되었습니다. 이러한 자원의 전환은 AED 홍보 및 배포를 포함한 다른 의료 분야에 대한 관심에 영향을 미칠 수 있습니다.
목차
제1장 시장 범위와 조사 방법
- 시장의 정의
- 목적
- 시장 범위
- 세분화
- 조사 방법
제2장 시장 요람
제3장 시장 개요
- 서론
- 시장에 영향을 미치는 주요 요인
- 시장 성장 촉진요인
- 시장 기회
- 시장 성장 억제요인
- 시장이 해결해야 할 과제
- Porter의 Five Forces 분석
제4장 자동 체외 제세동기 시장에서 전개되는 전략
제5장 세계 시장 : 제품별
- 세계의 완전 자동화 시장 : 지역별
- 세계의 반자동 시장 : 지역별
제6장 세계 시장 : 최종 용도별
- 세계의 병원 시장 : 지역별
- 세계의 병원전(Pre Hospital) 시장 : 지역별
- 세계의 퍼블릭 액세스 시장 : 지역별
- 세계의 홈케어 시장 : 지역별
- 세계의 기타 시장 : 지역별
제7장 세계 시장 : 지역별
- 북미
- 유럽
- 유럽 시장 : 국가별
- 독일
- 영국
- 프랑스
- 러시아
- 스페인
- 이탈리아
- 기타 유럽
- 아시아태평양
- 아시아태평양 시장 : 국가별
- 중국
- 일본
- 인도
- 한국
- 싱가포르
- 말레이시아
- 기타 아시아태평양
- 라틴아메리카/중동 및 아프리카
- 라틴아메리카/중동 및 아프리카 시장 : 국가별
- 브라질
- 아르헨티나
- 아랍에미리트(UAE)
- 사우디아라비아
- 남아프리카공화국
- 나이지리아
- 기타 라틴아메리카/중동 및 아프리카
제8장 기업 개요
- Nihon Kohden Corporation(Defibtech LLC)
- Koninklijke Philips NV
- Bpl Medical Technologies Private Limited
- Corpuls(Nordic Capital)
- Progetti SRL
- Stryker Corporation(HeartSine Technologies, Ltd)
- CU Medical Systems, Inc
- Silverline Meditech Pvt Ltd.
- AMI Italia Sr.l
- Medtronic PLC
제9장 자동 체외 제세동기 시장을 위한 성공 필수 조건
LSH
The Global Automated External Defibrillator Market size is expected to reach $3.1 billion by 2030, rising at a market growth of 9.6% CAGR during the forecast period. In the year 2022, the market attained a volume of 8,765.9 hundred units, experiencing a growth of 9.0% (2019-2022).
AEDs in the public access segment are often integrated into broader emergency response systems. Consequently, the public access segment captured $248.3 million revenue in the market in 2022. Also, the Germany market consumed 99.8 hundred units by public access in the market in 2022. Public access defibrillation programs aim to deploy AEDs across entire communities. These initiatives increase the density of AEDs in neighbourhoods, enhancing the chances of immediate intervention in the event of sudden cardiac arrest. Some devices have features that automatically notify emergency services when the AED is in use, facilitating a coordinated response.
Telemedicine integration enables healthcare professionals to assess the situation remotely and provide expert consultation on AED usage. AEDs connected to telemedicine services provide immediate access to medical expertise, regardless of the geographical location of the incident. This ensures that individuals in remote or underserved areas can access timely and high-quality medical guidance during critical moments.
Additionally, the senior population is more susceptible to cardiovascular diseases, such as coronary artery disease, heart failure, and arrhythmias. As per the World Health Organization, one in six people will be 60 or older by 2030. The number of people 60 and older in the world will increase from 1 billion in 2020 to 1.4 billion in 2050. By 2050, there will be 2.1 billion people in the world who are 60 or older. It is anticipated that there will be 426 million persons 80 or older by 2050.
However, small businesses with limited budgets can find the costs associated with AED maintenance and training prohibitive. Organizations may depend on external training providers, and the associated costs may vary. Relying on external entities for training can lead to unpredictable expenses, making it challenging for businesses and institutions to budget effectively. Thus, maintenance and training expenses can slow down the growth of the market.
Moreover, the global disruption in manufacturing and supply chains affected the production and distribution of medical devices, including AEDs. Restrictions on movement, lockdowns, and workforce shortages led to delays and disruptions in the supply of AEDs. The pandemic strained healthcare resources, with a significant focus on managing and treating COVID-19 cases. This diversion of resources potentially impacted the attention given to other areas of healthcare, including the promotion and deployment of AEDs.
By Product Analysis
By product, the market is categorized into fully-automated and semi-automated. The semi-automated segment covered a 29.15% revenue share in the market in 2022. In terms of volume, semi-automated segment would register 5,823.1 hundred units by 2030. Semi-automated AEDs provide a balanced approach by allowing the user to initiate the shock delivery after the device analyzes the heart rhythm. This balance between automated analysis and user-controlled shock delivery enables user involvement while ensuring prompt emergency response.
By End-use Analysis
Based on end-use, the market is classified into hospital, pre hospital, public access, homecare and others. In 2022, the hospital segment witnessed the 38.14% revenue share in the market. In terms of volume, hospital segment would consume 7,005.3 hundred units by 2030. Hospitals deploy AEDs in critical care units, such as intensive care units (ICUs) and coronary care units (CCUs). These devices respond rapidly to sudden cardiac arrest (SCA) within the hospital setting, complementing the comprehensive care offered to critically ill patients.
By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired a significant revenue share in the market. In terms of volume, Asia Pacific segment consumed 2,384.0 hundred units in 2022. The increasing incidence of cardiovascular diseases in the Asia Pacific region has heightened awareness of the need for effective emergency response measures. Integrating AEDs into emergency medical services (EMS) systems enhances the overall emergency response infrastructure in Asia Pacific.
Market Competition and Attributes
The market is marked by robust competition among leading players such as Koninklijke Philips N.V., Stryker Corporation, Corpuls, and Nihon Kohden Corporation. This competition is fueled by ongoing technological advancements, a focus on product quality and reliability, expansive distribution networks, adherence to regulatory standards, and strategic pricing tactics. Companies continually strive to differentiate their offerings through innovation while expanding into emerging markets and raising awareness about the critical role of AEDs in public safety, thus intensifying the competitive landscape within the industry.
Recent Strategies Deployed in the Market
- Oct-2023: Medtronic PLC has received FDA approval for the Aurora EV-ICDTM MRI SureScanTM (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScanTM defibrillation leads to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest (SCA). This Aurora EV-ICD system is a tremendous step forward in implantable defibrillator technology.
- Apr-2023: Defibtech LLC, a subsidiary of Nihon Kohden Corporation, announced the launch of the ARM XR, the next evolution of their automated CPR device. ARM XR is launched for use by emergency medical professionals to treat patients who are in cardiac arrest.
- Apr-2023: Medtronic PLC launched MRI Care Pathway, a new system that can streamline the process of completing MRI scans for patients with Medtronic MRI-compatible cardiac devices. Through this launch, Medtronic is conducting safe MRI scans for patients, which can ultimately reduce a patient's time waiting for important imaging data.
- Aug-2022: Medtronic PLC came into partnership with BioIntelliSense, a continuous health monitoring and clinical intelligence company for the exclusive U.S. hospital. Through this partnership, the company will provide connected care from in-hospital to home and expand our reach to help more patients in more places than ever before.
List of Key Companies Profiled
- Nihon Kohden Corporation (Defibtech LLC)
- Koninklijke Philips N.V.
- Bpl Medical Technologies Private Limited
- Corpuls (Nordic Capital)
- Progetti SRL
- Stryker Corporation (HeartSine Technologies, Ltd.)
- CU Medical Systems, Inc.
- Silverline Meditech Pvt. Ltd.
- AMI Italia S.r.l.
- Medtronic PLC
Global Automated External Defibrillator Market Report Segmentation
By Product (Volume, Hundred Units, USD Billion, 2019-2030)
- Fully-automated
- Semi-automated
By End-use (Volume, Hundred Units, USD Billion, 2019-2030)
- Hospital
- Pre Hospital
- Public Access
- Homecare
- Others
By Geography (Volume, Hundred Units, USD Billion, 2019-2030)
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1Global Automated External Defibrillator Market, by Product
- 1.4.2Global Automated External Defibrillator Market, by End-use
- 1.4.3Global Automated External Defibrillator Market, by Geography
- 1.5Methodology for the research
Chapter 2.Market at a Glance
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.Strategies Deployed in Automated External Defibrillator Market
Chapter 5.Global Automated External Defibrillator Market by Product
- 5.1Global Fully-automated Market by Region
- 5.2Global Semi-automated Market by Region
Chapter 6.Global Automated External Defibrillator Market by End-use
- 6.1Global Hospital Market by Region
- 6.2Global Pre Hospital Market by Region
- 6.3Global Public Access Market by Region
- 6.4Global Homecare Market by Region
- 6.5Global Others Market by Region
Chapter 7.Global Automated External Defibrillator Market by Region
- 7.1North America Automated External Defibrillator Market
- 7.1.1North America Automated External Defibrillator Market by Product
- 7.1.1.1North America Fully-automated Market by Country
- 7.1.1.2North America Semi-automated Market by Country
- 7.1.2North America Automated External Defibrillator Market by End-use
- 7.1.2.1North America Hospital Market by Country
- 7.1.2.2North America Pre Hospital Market by Country
- 7.1.2.3North America Public Access Market by Country
- 7.1.2.4North America Homecare Market by Country
- 7.1.2.5North America Others Market by Country
- 7.1.3North America Automated External Defibrillator Market by Country
- 7.1.3.1US Automated External Defibrillator Market
- 7.1.3.1.1US Automated External Defibrillator Market by Product
- 7.1.3.1.2US Automated External Defibrillator Market by End-use
- 7.1.3.2Canada Automated External Defibrillator Market
- 7.1.3.2.1Canada Automated External Defibrillator Market by Product
- 7.1.3.2.2Canada Automated External Defibrillator Market by End-use
- 7.1.3.3Mexico Automated External Defibrillator Market
- 7.1.3.3.1Mexico Automated External Defibrillator Market by Product
- 7.1.3.3.2Mexico Automated External Defibrillator Market by End-use
- 7.1.3.4Rest of North America Automated External Defibrillator Market
- 7.1.3.4.1Rest of North America Automated External Defibrillator Market by Product
- 7.1.3.4.2Rest of North America Automated External Defibrillator Market by End-use
- 7.2Europe Automated External Defibrillator Market
- 7.2.1Europe Automated External Defibrillator Market by Product
- 7.2.1.1Europe Fully-automated Market by Country
- 7.2.1.2Europe Semi-automated Market by Country
- 7.2.2Europe Automated External Defibrillator Market by End-use
- 7.2.2.1Europe Hospital Market by Country
- 7.2.2.2Europe Pre Hospital Market by Country
- 7.2.2.3Europe Public Access Market by Country
- 7.2.2.4Europe Homecare Market by Country
- 7.2.2.5Europe Others Market by Country
- 7.2.3Europe Automated External Defibrillator Market by Country
- 7.2.3.1Germany Automated External Defibrillator Market
- 7.2.3.1.1Germany Automated External Defibrillator Market by Product
- 7.2.3.1.2Germany Automated External Defibrillator Market by End-use
- 7.2.3.2UK Automated External Defibrillator Market
- 7.2.3.2.1UK Automated External Defibrillator Market by Product
- 7.2.3.2.2UK Automated External Defibrillator Market by End-use
- 7.2.3.3France Automated External Defibrillator Market
- 7.2.3.3.1France Automated External Defibrillator Market by Product
- 7.2.3.3.2France Automated External Defibrillator Market by End-use
- 7.2.3.4Russia Automated External Defibrillator Market
- 7.2.3.4.1Russia Automated External Defibrillator Market by Product
- 7.2.3.4.2Russia Automated External Defibrillator Market by End-use
- 7.2.3.5Spain Automated External Defibrillator Market
- 7.2.3.5.1Spain Automated External Defibrillator Market by Product
- 7.2.3.5.2Spain Automated External Defibrillator Market by End-use
- 7.2.3.6Italy Automated External Defibrillator Market
- 7.2.3.6.1Italy Automated External Defibrillator Market by Product
- 7.2.3.6.2Italy Automated External Defibrillator Market by End-use
- 7.2.3.7Rest of Europe Automated External Defibrillator Market
- 7.2.3.7.1Rest of Europe Automated External Defibrillator Market by Product
- 7.2.3.7.2Rest of Europe Automated External Defibrillator Market by End-use
- 7.3Asia Pacific Automated External Defibrillator Market
- 7.3.1Asia Pacific Automated External Defibrillator Market by Product
- 7.3.1.1Asia Pacific Fully-automated Market by Country
- 7.3.1.2Asia Pacific Semi-automated Market by Country
- 7.3.2Asia Pacific Automated External Defibrillator Market by End-use
- 7.3.2.1Asia Pacific Hospital Market by Country
- 7.3.2.2Asia Pacific Pre Hospital Market by Country
- 7.3.2.3Asia Pacific Public Access Market by Country
- 7.3.2.4Asia Pacific Homecare Market by Country
- 7.3.2.5Asia Pacific Others Market by Country
- 7.3.3Asia Pacific Automated External Defibrillator Market by Country
- 7.3.3.1China Automated External Defibrillator Market
- 7.3.3.1.1China Automated External Defibrillator Market by Product
- 7.3.3.1.2China Automated External Defibrillator Market by End-use
- 7.3.3.2Japan Automated External Defibrillator Market
- 7.3.3.2.1Japan Automated External Defibrillator Market by Product
- 7.3.3.2.2Japan Automated External Defibrillator Market by End-use
- 7.3.3.3India Automated External Defibrillator Market
- 7.3.3.3.1India Automated External Defibrillator Market by Product
- 7.3.3.3.2India Automated External Defibrillator Market by End-use
- 7.3.3.4South Korea Automated External Defibrillator Market
- 7.3.3.4.1South Korea Automated External Defibrillator Market by Product
- 7.3.3.4.2South Korea Automated External Defibrillator Market by End-use
- 7.3.3.5Singapore Automated External Defibrillator Market
- 7.3.3.5.1Singapore Automated External Defibrillator Market by Product
- 7.3.3.5.2Singapore Automated External Defibrillator Market by End-use
- 7.3.3.6Malaysia Automated External Defibrillator Market
- 7.3.3.6.1Malaysia Automated External Defibrillator Market by Product
- 7.3.3.6.2Malaysia Automated External Defibrillator Market by End-use
- 7.3.3.7Rest of Asia Pacific Automated External Defibrillator Market
- 7.3.3.7.1Rest of Asia Pacific Automated External Defibrillator Market by Product
- 7.3.3.7.2Rest of Asia Pacific Automated External Defibrillator Market by End-use
- 7.4LAMEA Automated External Defibrillator Market
- 7.4.1LAMEA Automated External Defibrillator Market by Product
- 7.4.1.1LAMEA Fully-automated Market by Country
- 7.4.1.2LAMEA Semi-automated Market by Country
- 7.4.2LAMEA Automated External Defibrillator Market by End-use
- 7.4.2.1LAMEA Hospital Market by Country
- 7.4.2.2LAMEA Pre Hospital Market by Country
- 7.4.2.3LAMEA Public Access Market by Country
- 7.4.2.4LAMEA Homecare Market by Country
- 7.4.2.5LAMEA Others Market by Country
- 7.4.3LAMEA Automated External Defibrillator Market by Country
- 7.4.3.1Brazil Automated External Defibrillator Market
- 7.4.3.1.1Brazil Automated External Defibrillator Market by Product
- 7.4.3.1.2Brazil Automated External Defibrillator Market by End-use
- 7.4.3.2Argentina Automated External Defibrillator Market
- 7.4.3.2.1Argentina Automated External Defibrillator Market by Product
- 7.4.3.2.2Argentina Automated External Defibrillator Market by End-use
- 7.4.3.3UAE Automated External Defibrillator Market
- 7.4.3.3.1UAE Automated External Defibrillator Market by Product
- 7.4.3.3.2UAE Automated External Defibrillator Market by End-use
- 7.4.3.4Saudi Arabia Automated External Defibrillator Market
- 7.4.3.4.1Saudi Arabia Automated External Defibrillator Market by Product
- 7.4.3.4.2Saudi Arabia Automated External Defibrillator Market by End-use
- 7.4.3.5South Africa Automated External Defibrillator Market
- 7.4.3.5.1South Africa Automated External Defibrillator Market by Product
- 7.4.3.5.2South Africa Automated External Defibrillator Market by End-use
- 7.4.3.6Nigeria Automated External Defibrillator Market
- 7.4.3.6.1Nigeria Automated External Defibrillator Market by Product
- 7.4.3.6.2Nigeria Automated External Defibrillator Market by End-use
- 7.4.3.7Rest of LAMEA Automated External Defibrillator Market
- 7.4.3.7.1Rest of LAMEA Automated External Defibrillator Market by Product
- 7.4.3.7.2Rest of LAMEA Automated External Defibrillator Market by End-use
Chapter 8.Company Profiles
- 8.1Nihon Kohden Corporation (Defibtech LLC)
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Product Category and Regional Analysis
- 8.1.4Research & Development Expenses
- 8.1.5Recent strategies and developments:
- 8.1.5.1Product Launches and Product Expansions:
- 8.1.6SWOT Analysis
- 8.2Koninklijke Philips N.V.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
- 8.2.5.1Product Launches and Product Expansions:
- 8.2.5.2Trials / Approvals:
- 8.2.6SWOT Analysis
- 8.3Bpl Medical Technologies Private Limited
- 8.3.1Company Overview
- 8.3.2SWOT Analysis
- 8.4Corpuls (Nordic Capital)
- 8.4.1Company Overview
- 8.4.2SWOT Analysis
- 8.5Progetti SRL
- 8.5.1Company Overview
- 8.5.2SWOT Analysis
- 8.6Stryker Corporation (HeartSine Technologies, Ltd.)
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental and Regional Analysis
- 8.6.4Research & Development Expenses
- 8.6.5Recent strategies and developments:
- 8.6.5.1Product Launches and Product Expansions:
- 8.6.6SWOT Analysis
- 8.7CU Medical Systems, Inc.
- 8.7.1Company Overview
- 8.7.2SWOT Analysis
- 8.8Silverline Meditech Pvt. Ltd.
- 8.9AMI Italia S.r.l.
- 8.10.Medtronic PLC
- 8.10.1Company overview
- 8.10.2Financial Analysis
- 8.10.3Segmental and Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5Recent strategies and developments:
- 8.10.5.1Partnerships, Collaborations, and Agreements:
- 8.10.5.2Product Launches and Product Expansions:
- 8.10.5.3Trials / Approvals:
- 8.10.6SWOT Analysis
Chapter 9.Winning Imperatives of Automated External Defibrillator Market
